Ribosome profiling, or Ribo-Seq, is based on large-scale sequencing of RNA fragments protected from nuclease digestion by ribosomes. Thanks to its unique ability to provide positional information about ribosomes flowing along transcripts, this method can be used to shed light on mechanistic aspects of translation. However, current Ribo-Seq approaches lack the ability to distinguish between fragments protected either by ribosomes in active translation or by inactive ribosomes. To overcome this significant limitation, we developed RiboLace: a novel method based on an original puromycin-containing molecule capable of isolating active ribosomes by means of an antibody-free and tag-free pulldown approach. RiboLace is fast, works reliably with low amounts of input material, and can be easily and rapidly applied both in vitro and in vivo, thereby generating a global snapshot of active ribosome footprints at single nucleotide resolution.
Clamer, Massimiliano and Tebaldi, Toma and Lauria, Fabio and Bernabò, Paola and Gómez-Biagi, Rodolfo F. and Perenthaler, Elena and Gubert, Daniele and Pasquardini, Laura and Guella, Graziano and Groen, Ewout J. N. and Gillingwater, Thomas H. and Quattrone, Alessandro and Viero, Gabriella, Active Ribosome Profiling With RiboLace (2018). Available at SSRN: https://ssrn.com/abstract=3155822 or http://dx.doi.org/10.2139/ssrn.3155822
This version of the paper has not been formally peer reviewed.
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
20
PAPERS
9,160
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.